Regular monitoring of lipid panels, hemoglobin A1c, blood pressure, and renal function is appropriate for patients on GLP-1 therapy
Hyperhomocysteinemia: An Expected Causal Risk Factor for Atherothrombosis
References National Library of Medicine
Some patients experience renewed confidence and intimacy, while others may face unexpected challenges as their physical appearance changes
While gastrointestinal side effects like nausea and diarrhea are well-documented, some patients report flu-like symptoms during treatment
GLP-1s are powerful appetite suppressants, and for individuals with a history of restriction, bingeing, purging, or body image struggles, they can be destabilizing